| 000 | 02140 a2200649 4500 | ||
|---|---|---|---|
| 005 | 20250515141104.0 | ||
| 264 | 0 | _c20090507 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/onc.2008.385 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNoborio-Hatano, K | |
| 245 | 0 | 0 |
_aBortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma. _h[electronic resource] |
| 260 |
_bOncogene _cJan 2009 |
||
| 300 |
_a231-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aCell Adhesion _xphysiology |
| 650 | 0 | 4 |
_aCell Adhesion Molecules _xphysiology |
| 650 | 0 | 4 |
_aCell Line, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntegrin alpha Chains _xbiosynthesis |
| 650 | 0 | 4 |
_aIntegrin alpha4 _xbiosynthesis |
| 650 | 0 | 4 |
_aIntegrin alpha4beta1 _xphysiology |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 |
_aVincristine _xpharmacology |
| 700 | 1 | _aKikuchi, J | |
| 700 | 1 | _aTakatoku, M | |
| 700 | 1 | _aShimizu, R | |
| 700 | 1 | _aWada, T | |
| 700 | 1 | _aUeda, M | |
| 700 | 1 | _aNobuyoshi, M | |
| 700 | 1 | _aOh, I | |
| 700 | 1 | _aSato, K | |
| 700 | 1 | _aSuzuki, T | |
| 700 | 1 | _aOzaki, K | |
| 700 | 1 | _aMori, M | |
| 700 | 1 | _aNagai, T | |
| 700 | 1 | _aMuroi, K | |
| 700 | 1 | _aKano, Y | |
| 700 | 1 | _aFurukawa, Y | |
| 700 | 1 | _aOzawa, K | |
| 773 | 0 |
_tOncogene _gvol. 28 _gno. 2 _gp. 231-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2008.385 _zAvailable from publisher's website |
| 999 |
_c18314870 _d18314870 |
||